
| Platform | Pricing | Freemium | Publishes | Daily | |
|---|---|---|---|---|---|
| Issues | 1233 | Founded | 10 months ago | Last Issue | 5 days ago |
| Active | |||||

The BEST1 Cohort 1 topline now has a timestamp — September 9 — and the stock has already run 19.6% into it, from $3.72 to $4.45.
This Substack is reader-supported. To receive new posts and support my work, consider becoming a free or paid...
The AMT-130 filing landed in Q3 as promised, with a parallel UK MAA and a priority review request — and the four-year Huntington’s readout is now due inside four weeks
This Substack is reader-supported. To receive new posts and support my...
HARMONi-2’s preplanned OS analysis has ivonescimab monotherapy beating pembrolizumab monotherapy in PD-L1-positive NSCLC — the third Phase III OS win over a checkpoint inhibitor, and the first against
This Substack is reader-supported. To...
A five-year commercial supply agreement with Hovione for bezuclastinib tablets lands 90 days before the GIST PDUFA — and the stock has given back 16.8% since the August ATM.
This Substack is reader-supported. To receive new posts and suppo...
Geoff Parker retires effective November 6 — the second C-suite exit in three months, and the one that sits closest to the $135M facility I’ve been calling the weakest part of this story.
This Substack is reader-supported. To receive new po...
Subscribers, engagement, traffic and sponsorship for Biotech Distilled.
| Subscribers | Engagement | 80 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
How this newsletter ranks in the official Substack charts.
| #51 |
The writers behind this newsletter.
PhD in Medicinal Chemistry. Senior Patent Agent. Extensive experience evaluating drug discovery programs — from molecular mechanism to clinical plausibility.
You can find recent issues that have been published by Biotech Distilled on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to Biotech Distilled, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch Biotech Distilled as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Biotech Distilled using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Related Newsletters to see other publications like Biotech Distilled. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.